Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis

<p>Abstract</p> <p>Background</p> <p>Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysi...

Full description

Bibliographic Details
Main Authors: Zafar Syed, Khan Abdul, Ghauri Asfar, Shamim Muhammad
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Neurology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2377/12/30
id doaj-5cef1121974f4661854ae5ea2f8f34a2
record_format Article
spelling doaj-5cef1121974f4661854ae5ea2f8f34a22020-11-25T01:39:47ZengBMCBMC Neurology1471-23772012-05-011213010.1186/1471-2377-12-30Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysisZafar SyedKhan AbdulGhauri AsfarShamim Muhammad<p>Abstract</p> <p>Background</p> <p>Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury<it>.</it></p> <p>Methods</p> <p>An electronic search was performed in using Pubmed, Embase, and CENTRAL. We included studies that compared the use of LEV vs. PHY for seizure prophylaxis for brain injured patients (Traumatic brain injury, intracranial hemorrhage, intracranial neoplasms, and craniotomy). Data of all eligible studies was extracted on to a standardized abstraction sheet. Data about baseline population characteristics, type of intervention, study design and outcome was extracted. Our primary outcome was seizures.</p> <p>Results</p> <p>The literature search identified 2489 unduplicated papers. Of these 2456 papers were excluded by reading the abstracts and titles. Another 25 papers were excluded after reading their complete text. We selected 8 papers which comprised of 2 RCTs and 6 observational studies. The pooled estimate’s Odds Ratio 1.12 (95% CI = 0.34, 3.64) demonstrated no superiority of either drug at preventing the occurrence of early seizures. In a subset analysis of studies in which follow up for seizures lasted either 3 or 7 days, the effect estimate remained insignificant with an odds ratio of 0.96 (95% CI = 0.34, 2.76). Similarly, 2 trials reporting seizure incidence at 6 months also had insignificant pooled results while comparing drug efficacy. The pooled odds ratio was 0.96 (95% CI = 0.24, 3.79).</p> <p>Conclusions</p> <p>Levetiracetam and Phenytoin demonstrate equal efficacy in seizure prevention after brain injury. However, very few randomized controlled trials (RCTs) on the subject were found. Further evidence through a high quality RCT is highly recommended.</p> http://www.biomedcentral.com/1471-2377/12/30LevetiracetamPhenytoinMeta-analysisBrain injurySeizuresProphylaxisAnti-epileptic drugs
collection DOAJ
language English
format Article
sources DOAJ
author Zafar Syed
Khan Abdul
Ghauri Asfar
Shamim Muhammad
spellingShingle Zafar Syed
Khan Abdul
Ghauri Asfar
Shamim Muhammad
Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
BMC Neurology
Levetiracetam
Phenytoin
Meta-analysis
Brain injury
Seizures
Prophylaxis
Anti-epileptic drugs
author_facet Zafar Syed
Khan Abdul
Ghauri Asfar
Shamim Muhammad
author_sort Zafar Syed
title Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
title_short Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
title_full Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
title_fullStr Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
title_full_unstemmed Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysis
title_sort phenytoin versus leviteracetam for seizure prophylaxis after brain injury – a meta analysis
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2012-05-01
description <p>Abstract</p> <p>Background</p> <p>Current standard therapy for seizure prophylaxis in Neuro-surgical patients involves the use of Phenytoin (PHY). However, a new drug Levetiracetam (LEV) is emerging as an alternate treatment choice. We aimed to conduct a meta-analysis to compare these two drugs in patients with brain injury<it>.</it></p> <p>Methods</p> <p>An electronic search was performed in using Pubmed, Embase, and CENTRAL. We included studies that compared the use of LEV vs. PHY for seizure prophylaxis for brain injured patients (Traumatic brain injury, intracranial hemorrhage, intracranial neoplasms, and craniotomy). Data of all eligible studies was extracted on to a standardized abstraction sheet. Data about baseline population characteristics, type of intervention, study design and outcome was extracted. Our primary outcome was seizures.</p> <p>Results</p> <p>The literature search identified 2489 unduplicated papers. Of these 2456 papers were excluded by reading the abstracts and titles. Another 25 papers were excluded after reading their complete text. We selected 8 papers which comprised of 2 RCTs and 6 observational studies. The pooled estimate’s Odds Ratio 1.12 (95% CI = 0.34, 3.64) demonstrated no superiority of either drug at preventing the occurrence of early seizures. In a subset analysis of studies in which follow up for seizures lasted either 3 or 7 days, the effect estimate remained insignificant with an odds ratio of 0.96 (95% CI = 0.34, 2.76). Similarly, 2 trials reporting seizure incidence at 6 months also had insignificant pooled results while comparing drug efficacy. The pooled odds ratio was 0.96 (95% CI = 0.24, 3.79).</p> <p>Conclusions</p> <p>Levetiracetam and Phenytoin demonstrate equal efficacy in seizure prevention after brain injury. However, very few randomized controlled trials (RCTs) on the subject were found. Further evidence through a high quality RCT is highly recommended.</p>
topic Levetiracetam
Phenytoin
Meta-analysis
Brain injury
Seizures
Prophylaxis
Anti-epileptic drugs
url http://www.biomedcentral.com/1471-2377/12/30
work_keys_str_mv AT zafarsyed phenytoinversusleviteracetamforseizureprophylaxisafterbraininjuryametaanalysis
AT khanabdul phenytoinversusleviteracetamforseizureprophylaxisafterbraininjuryametaanalysis
AT ghauriasfar phenytoinversusleviteracetamforseizureprophylaxisafterbraininjuryametaanalysis
AT shamimmuhammad phenytoinversusleviteracetamforseizureprophylaxisafterbraininjuryametaanalysis
_version_ 1725049186024423424